Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,189.55
-24.50 (-1.11%)
At close: Jun 22, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 618.56 billion as of June 22, 2026. Its market cap has increased by 46.37% in one year.
Market Cap
618.56B
Enterprise Value
612.73B
Revenue
169.83B
Ranking
n/a
PE Ratio
45.42
Stock Price
2,189.55
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 618.56B, an increase of 53,720.08%. That is a compound annual growth rate of 28.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 618.56B | 7.70% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.50T |
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |